Molecular strategies to inhibit ABC Transporters in Prevotella intermedia: Overcoming Periodontal Pathogenesis via Molecular Modelling and docking studies

Authors

  • Snigdha Bharadwaz
  • Jishnu

Keywords:

Prevotella intermedia; ABC transporters; Molecular docking; Periodontal disease; Antimicrobial peptides; ClusPro; Computational drug design

Abstract

Periodontal diseases, including gingivitis and periodontitis, are chronic inflammatory conditions driven by complex microbial interactions within the oral cavity. Prevotella intermedia, a Gram-negative anaerobic bacterium, is a key contributor to periodontal pathogenesis due to its virulence factors and ability to thrive in subgingival environments. Among its survival mechanisms, ATP-binding cassette (ABC) transporters play a crucial role in nutrient acquisition, toxin efflux, and antimicrobial resistance. This study aims to explore molecular strategies for inhibiting ABC transporters in P. intermedia using computational approaches such as molecular modelling and docking analysis. The three-dimensional structure of the ABC transporter protein was retrieved from the RCSB Protein Data Bank, while potential inhibitory ligands were selected from the Antimicrobial Peptide Database. Molecular docking was performed using ClusPro to evaluate protein–ligand interactions. The results demonstrated that selected peptides exhibited favorable binding affinities and stable interactions with key functional domains of the transporter. These findings suggest that targeting ABC transporters could impair bacterial survival and reduce pathogenicity. However, further experimental validation is required to confirm these computational predictions. This study highlights the potential of computational drug design in identifying novel therapeutic targets for periodontal diseases and provides a foundation for future translational research

Downloads

Download data is not yet available.

References

Wu T, Jiang W. Computational-aided drug design strategies for drug discovery and development against oral diseases. Frontiers in Pharmacology. 2025 Nov 7;16:1678652.

2. Li Y, He X, Luo G, Zhao J, Bai G, Xu D. Innovative strategies targeting oral microbial dysbiosis: unraveling mechanisms and advancing therapies for periodontitis. Frontiers in cellular and infection microbiology. 2025 Apr 30;15:1556688.

3. Anika A. Targeting Porphyromonas gingivalis in Oral and Esophageal Cancer: A Bioinformatic and Medicinal Plant-Based Approach (Doctoral dissertation, AUW).

4. Alqarni, A., Hosmani, J., Alassiri, S.A., Al Qahtani, A.F.A., Al Magbol, M., Almubarak, H. and Patil, S., 2025. Periodontal Implications of Porphyromonas gingivalis-Derived Metabolites in Host Antioxidant and Anti-Inflammatory Mechanisms: A Computational Analysis. Medical science monitor: international medical journal of experimental and clinical research, 31, p.e949167.

5. Hashim NT, Babiker R, Chaitanya NC, Mohammed R, Priya SP, Padmanabhan V, Ahmed A, Dasnadi SP, Islam MS, Gismalla BG, Rahman MM. New insights in natural bioactive compounds for periodontal disease: advanced molecular mechanisms and therapeutic potential. Molecules. 2025 Feb 10;30(4):807.

6. Alam M, Gulzar M, Akhtar MS, Rashid S, Zulfareen, Tanuja, Shamsi A, Hassan MI. Epigallocatechin-3-gallate therapeutic potential in human diseases: molecular mechanisms and clinical studies. Molecular biomedicine. 2024 Dec 27;5(1):73.

7. Zarzosa-Moreno D, Avalos-Gómez C, Ramírez-Texcalco LS, Torres-López E, Ramírez-Mondragón R, Hernández-Ramírez JO, Serrano-Luna J, de la Garza M. Lactoferrin and its derived peptides: an alternative for combating virulence mechanisms developed by pathogens. Molecules. 2020 Dec 8;25(24):5763.

8. Malešević M, Jovčić B. Targeting Gram-Negative bacterial biofilm with innovative therapies: communication Silencing strategies. Future Pharmacology. 2025 Jul 3;5(3):35.

9. Gogeneni H. Porphyromonas gingivalis infection in gestational diabetes mellitus and survival in tobacco smokers.

10. Barros CH, Casey E. A review of nanomaterials and technologies for enhancing the antibiofilm activity of natural products and phytochemicals. ACS Applied Nano Materials. 2020 Aug 4;3(9):8537-56.

11. Chan NA. Discovery ofemph {Klebsiella aerogenes} CDI Receptor and Investigation of the Binding in the Receptor (Doctoral dissertation, UC Santa Barbara).

Downloads

Published

2025-12-12

How to Cite

1.
Bharadwaz S, Jishnu J. Molecular strategies to inhibit ABC Transporters in Prevotella intermedia: Overcoming Periodontal Pathogenesis via Molecular Modelling and docking studies. J Neonatal Surg [Internet]. 2025 Dec. 12 [cited 2026 May 9];14(33S):1031-7. Available from: https://jneonatalsurg.com/index.php/jns/article/view/10243